Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...
MRT is not legal in the U.S. But medical tourism agencies charge thousands of dollars to connect women to clinics around the ...
A person in Washington state has died from complications of the bird flu, the first such U.S. death in a year.
Pharmalittle: We’re reading about payments to Russian middlemen, a possible Dupixent rival, and more
Four big drugmakers allegedly paid tens of millions of dollars to middlemen to supply lifesaving drugs to Russian government ...
No matter what happens on Election Day, the midterms will have sweeping implications for American health care. More than two ...
The task force is a critical advisory body to HHS, reviewing scientific evidence to provide recommendations on whether ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results